Advertisement

Topics

Recordati S.p.A. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

18:44 EDT 3 Sep 2017 | BioPortfolio Reports

Recordati S.p.A. Strategy, SWOT and Corporate Finance Report

Summary

Recordati S.p.A. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Recordati S.p.A. Recordati or 'the group' is a specialty pharmaceutical company dedicated to the research, development, manufacturing and marketing of pharmaceutical products. The company has its presence in Europe, Australasia, Africa and America. It is headquartered in Milan, Italy, and employed about 4,000 people as on December 31, 2014.

Scope

Detailed information on Recordati S.p.A. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Recordati S.p.A. in the form of a SWOT analysis
An indepth view of the business model of Recordati S.p.A. including a breakdown and examination of key business segments
Intelligence on Recordati S.p.A.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Recordati S.p.A., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Recordati S.p.A. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Recordati S.p.A. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Recordati S.p.A.'s business structure, strategy and prospects.

Original Article: Recordati S.p.A. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Recordati S.p.A. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175"

Quick Search
Advertisement
 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...